MyAverix Finance
F · Healthcare
MediPharm Labs Corp (MLZ)
Drug Manufacturers - Specialty & Generic
MediPharm Labs Corp (MLZ) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $16.39M, P/E ratio is 18.00, net margin is -17.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MLZ
MediPharm Labs Corp (MLZ) — FAQ
What is MediPharm Labs Corp's market cap?
MediPharm Labs Corp (MLZ) has a reported market cap of $16.39M (data as of 2026-03-30).
What is MLZ's P/E ratio?
The price-to-earnings (P/E) ratio for MediPharm Labs Corp (MLZ) is 18.00 (data as of 2026-03-30).
Does MediPharm Labs Corp pay a dividend?
Dividend yield is not available in the current snapshot for MediPharm Labs Corp (MLZ). Check the MyAverix Finance app for the latest dividend data.
What sector is MediPharm Labs Corp in?
MediPharm Labs Corp (MLZ) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MLZ listed on?
MLZ is listed on F.
What is MediPharm Labs Corp's net margin?
MediPharm Labs Corp (MLZ) reports a net margin of -17.4% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.